Teicoplanin A2-3

SynDRA canonical compound SYN2099020 — structure-anchored drug synonym record

Clinical phase	Launched
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	gram-positive bacterial infections
Disease area	infectious disease

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Teichomycin A2 factor 3
6LN24Z7AMM
N-2-Decanoyl glucosamine teicoplanin
MFCD05664625
Teichomycin A2-3
Teicoplanin?A2-3
C13588
T-A2-3
UNII-6LN24Z7AMM
SCHEMBL874526
Teichomycin A(sub 2) factor 3
CHEBI:34996
TEICOPLANIN A2-3 [MI]
HY-130338
CS-0107367
NS00098730
C88H97Cl2N9O33
MFCD00871001
34-O-(2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-(2-deoxy-2-((1-oxodecyl)amino)-beta-D-glucopyranosyl)-42-O-alpha-D-mannopyranosylristomycin A aglycone
34-O-[2-(acetamido)-2-deoxy-beta-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-{2-deoxy-2-[(1-oxodecyl)amino]-beta-D-glucopyranosyl}-42-O-alpha-D-mannopyranosylristomycin A aglycone